Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PMC 2427333
[119] conducted a phase II clinical trial in patients with NASH, that is, a placebo-controlled trial of subcutaneous sommarutide in the treatment of NASH, and found that sommarutide treatment resulted in a significantly higher proportion of patients in remission of NASH compared with placebo
Normal activities, including work and exercise, can be resumed immediately after the treatment
This indicates that the integration of temporal features by means of LSTM with spatial features by means of CNN optimizes the performance of classification for skin lesion detection
They are fundamental components of all our tissues, including the skin
US$ 22.79
US$ 29.10
US$ 29.75
